tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Frank Takkinen, 88 are a BUY (97.78%), 2 are a HOLD (2.22%).
Analyst Frank Takkinen, currently employed at LAKE STREET, carries an average stock price target met ratio of 39.43% that have a potential upside of 37.95% achieved within 87 days.
Frank Takkinen’s has documented 176 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CLPT, Clearpoint Neuro at 27-Aug-2024.
Analyst best performing recommendations are on APYX (APYX MEDICAL).
The best stock recommendation documented was for NOTV (INOTIV) at 5/16/2024. The price target of $2 was fulfilled within 1 day with a profit of $0.14 (6.54%) receiving and performance score of 65.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$217
$13.01 (6.38%)
$280
2 months ago
16/27 (59.26%)
$71.18 (48.81%)
208
Hold
$170
$-33.99 (-16.66%)
$210
2 months 23 days ago
7/8 (87.5%)
$34.7 (25.65%)
54
Buy
$255
$51.01 (25.01%)
$305
4 months 8 days ago
20/21 (95.24%)
$91.59 (56.05%)
194
Buy
$225
$21.01 (10.30%)
$355
4 months 8 days ago
1/3 (33.33%)
$61.59 (37.69%)
348
Buy
$250
$46.01 (22.56%)
$250
5 months 20 days ago
5/7 (71.43%)
$36.5 (17.10%)
56
Which stock is Frank Takkinen is most bullish on?
Which stock is Frank Takkinen is most reserved on?
What Year was the first public recommendation made by Frank Takkinen?
